Results 161 to 170 of about 796,161 (328)
Jin-Young Chung+4 more
semanticscholar +1 more source
Through metabolomic and transcriptomic analyses, a glutamine‐enriched, immunosuppressive microenvironment is identified in cervical squamous cell carcinoma (CSCC), highlighting the glutamine transporter SLC25A22 as a key regulator of glutamine metabolism, immune checkpoint activation, and CD8+ T‐cell cytotoxicity.
Tingting Ren+7 more
wiley +1 more source
THE EFFECT OF ZERANOL IMPLANATION ON SOME ENDOCRINE GLANDS AND GONADS IN FAT-TAILED LAMBS II. THE TESTES [PDF]
openalex +1 more source
Clinical discovery and the proposed underlying mechanism by how P. johnsonii ameliorated metabolic disorders. Abstract The gut bacterium Parabacteroides spp. is increasingly recognized for its therapeutic potential in treating metabolic disorders. However, the role of Parabacteroides johnsonii in metabolic disorders is never reported.
Yimeng Chen+9 more
wiley +1 more source
Prospectively assessed hypothalamic-pituitary dysfunction after proton therapy in adults with head and neck, skull base and brain tumors. [PDF]
Bouter J+7 more
europepmc +1 more source
G-protéines oncogéniques et cancers des glandes endocrines [PDF]
A Kahn
openalex +1 more source
J. Lecouter+6 more
semanticscholar +1 more source
The study reveals that PAXIP1‐associated glutamate‐rich protein 1 (PAGR1), a glucose‐responsive regulator in skeletal muscle, modulates systemic glucose homeostasis and hepatic metabolism. Muscle‐specific PAGR1 deletion enhances insulin signaling, promotes glucose transporter 4 (GLUT4) translocation, and protects against high‐fat‐diet‐induced insulin ...
Chenyun Ding+19 more
wiley +1 more source